Search for Abstracts Find by Title, Author or Description Year Abstracts - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first O01 – Addressing Neuroendocrine Tumour Related Emotional Issues Published in 2016 Listed under Other Download Ardill O01 – An Ongoing, Double-Blind, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline® Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome Published in 2012 Listed under Other, Poster Download Edda Gomez-Panzani, Veronique Fohanno pdf Download Poster (183 KB) O01 – An Ongoing, Double-Blind, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline® Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome -- Update on the Current Status Published in 2011 Listed under Other, Poster Download Edda Gomez-Panzani, Stephen Chang, Nadine Knowles and Veronique Fohanno pdf Download Poster (90 KB) O01 – Integrating Patient Reported Outcomes (PROs) in Neuroendocrine Tumors (NETs) Care: An Assessment of Neuropsychological and Quality of Life Screening Tools Published in 2017 Listed under Other Download Hallet Abstract ID: 230 O01 – Neuroendocrine tumor (NET) Impact on Quality of Life (QOL) Patient Experience From the First Global NET Patient Survey: A Collaboration Between the International Neuroendocrine Cancer Alliance (INCA) and Novartis Pharmaceuticals Published in 2014 Listed under Other Download Goldstein O01 – Somatuline® Autogel® 120 mg (lanreotide) Evaluation of Tumor Progression-Free Survival in Patients with Non-Functioning Entero-Pancreatic Endocrine Tumors: An Ongoing, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study (the CLARINET Stu Published in 2010 Listed under Other Download Joëlle Blumberg, Edda Gomez-Panzani, Séverine Latapie- Martinezand Nilani Liyanage O02 – 68Ga-DOTATATE PET/CT Imaging for Advanced Neuroendocrine Carcinoma in the United States Published in 2011 Listed under Other Download Eric H. Liu, Jeff Clanton, Dominique Delbeke, Martin Sandler, Bill Martin, Ronald C. Walker O02 – Evidence of Improved Survival when Patients are Referred on to a Specialist NET Clinic with Multidisciplinary Team Management Published in 2016 Listed under Other Download Ardill O02 – The Distal Predilection of Small Bowel Neuroendocrine Tumors Published in 2017 Listed under Other, Poster Download Keck Abstract ID: 211 pdf Download Poster (1.01 MB) O02 – LX1606 / LX1032: A Serotonin Synthesis Inhibitor in a Randomized, Double-Blind Phase 2 Clinical Trial in the U.S. as a Novel Approach for Managing Gastrointestinal (GI) Symptoms in Carcinoid Syndrome Published in 2010 Listed under Other Download Phil Brown, Kenny Frazier, Jessica Jackson, Shanna Jackson, Joel Frieman, Brian Zambrowicz O03 – Blood Neuroendocrine Transcript Analysis for the Diagnosis and Clinical Status Assessment of Bronchopulmonary Neuroendocrine Tumors Published in 2017 Listed under Other Download Modlin Abstract ID: 296 O03 – What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision Analysis Published in 2016 Listed under Other, Poster Download Goetghebeur pdf Download Poster (1.03 MB) O03 – Open-Label Phase 2 Clinical Trial of LX1606 / LX1032 in Europe: A Novel Agent for Reducing Serotonin Production in Carcinoid Syndrome Published in 2010 Listed under Other Download Phil Brown, Kenny Frazier, Jessica Jackson, Shanna Jackson, Joel Frieman, Brian Zambrowicz O04 – Pancreatic Neuroendocrine Tumors: CT Enhancement, but not Histologic Grade, Correlates with Tumor Aggression Published in 2017 Listed under Other Download Yano Abstract ID: 201 O04 – To Treat or Watch? Identifying Drivers of Decisions for Patients with GEPNET Using Reflective Multi-Criteria Decision Analysis Published in 2016 Listed under Other Download Goetghebeur O04 – Bayesian Adaptive Study Design for Efficient Dose Finding for an Octreotide Implant in Patients with Carcinoid Syndrome (CS) Published in 2010 Listed under Other Download Carla Chieffo, Stephen A. Bai, Yusong Chen, Theodore M. Danoff O05 – A Case Series of 27 Primary Ovarian Neuroendocrine Tumors Published in 2016 Listed under Other Download Heskel O05 – 177 Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms; First Trial in U.S.A Published in 2010 Listed under Other Download Ebrahim S. Delpassand, M.D O06 – Retrospective Chart Review of Antidepressant Use in Patients with Carcinoid Tumors Published in 2016 Listed under Other, Poster Download Isenberg-Grzeda pdf Download Poster (254 KB) O06 – An Ongoing, Double-Blind, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline® Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome Published in 2010 Listed under Other Download Edda Gomez-Panzani, Stephen Chang, Joëlle Blumberg and Veronique Fohanno O07 – Antidepressant Use in Patients with Carcinoid Tumors: Results of A Systematic Review Published in 2016 Listed under Other, Poster Download Isenberg-Grzeda pdf Download Poster (383 KB) O07 – Tumor and Normal Tissue Uptake of 68Ga-DOTA-tyr3- Octreotide after Treatment with Unlabeled Octreotide in Patients with Carcinoid Tumors and Pancreatic Neuroendocrine Tumors Published in 2010 Listed under Other Download Yusuf Menda, MD, Michael Schultz, PhD, David Bushnell, MD, Thomas O’Dorisio, MD, M. Sue O’Dorisio, MD, PhD O08 – Renal Neuroendocrine Tumors (rNETs): A Single-center Experience Published in 2016 Listed under Other, Poster Download Scales pdf Download Poster (78 KB) O09 – Identifying and Prioritising Gaps in Neuroendocrine Tumour Researchresults of the Delphi Consensus Project of the Commonwealth Neuroendocrine Tumour Research Collaboration (CommNETS) Published in 2016 Listed under Other Download Segelov O1 - Neuroendocrine Wellness Clinic – Holistic Care Delivery to Patients With Metastatic Neuroendocrine Tumors Published in 2020 Listed under Other Download A. Laffan ABSTRACT ID: 79 O10 - The Use of Octreotide LAR in Routine Canadian Practice: Dosing Considerations and Persistence Rates Published in 2020 Listed under Other Download S. Singh, W. Cheung, H. Gourdeau ABSTRACT ID: 178 O10 – The Clinicopathologic Characteristics of Primary Presacral Neuroendocrine Tumor: A Single Center Experience Published in 2016 Listed under Other, Poster Download Yang pdf Download Poster (671 KB) O11 - Neuroendocrine Carcinoma of the Rectum & Anus: Patient Characteristics and Treatment Modalities Published in 2020 Listed under Other Download B. Ueberroth, A. Liu, T. Halfdanarson, M. Sonbol ABSTRACT ID: 191 O2 - Development and Validation of the Disease-Specific QOL-CD Quality of Life Questionnaire for Patients with Cushing’s Disease Published in 2020 Listed under Other Download M. Cusimano, T. Huang, A. Marchie, H. Smyth, K. Kovacs ABSTRACT ID: 108 O3 - Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN) – USA and Canada vs Global Diagnosis of NETs Published in 2020 Listed under Other Download E. Gellerman, J. Herman, M. McDonnell, D. Van Genechten, M. Pavel, D. O'Toole, H. Singh, J. Chen, J. Howe, S. Singh, C. Bouvier, C. Rodien-Louw, S. Leyden, S. Dureja, T. Kolarova ABSTRACT ID: 126 O4 - Identifying Care Processes Promoting Person-Centred Care for Patients Diagnosed With Neuroendocrine Tumours (NETs) Published in 2020 Listed under Other Download J. Hallet, V. Zuk, L. Moody, D. Chan, M. Michael, T. Halfdanarson, R. Pommier, S. Myrehaug, R. Goodwin, C. Law, J. Herman, S. Sohail, F. Wright, L. Gotlib Conn ABSTRACT ID: 129 O5 - Supporting Accurate Patient Information for An Uncommon Malignancy: Evaluation of the Quality of Information on Neuroendocrine Tumors (NETs) on the Internet Published in 2020 Listed under Other Download S. Sohail, V. Zuk, T. Halfdanarson, D. Chan, S. Pattison, R. Vasdev, C. Law ABSTRACT ID: 131 O6 - Diagnostic Effectiveness of Chromogranin A and Multigene Liquid Biopsy (NETest) in Neuroendocrine Neoplasia: An assessment of Monoanalyte and Multianalyte Biomarker Efficacy Published in 2020 Listed under Other Download A. Malczewska, K. Oberg, B. Kos-Kudla ABSTRACT ID: 153 O7 - Stereotactic Ablative Radiotherapy for the Management of Neuroendocrine Liver Metastases Published in 2020 Listed under Other Download J. Hudson, H. Chung, W. Chu, A. Taggar, L. Davis, J. Hallet, C. Law, S. Singh, S. Myrehaug ABSTRACT ID: 166 O8 - Role of Chromogranin A-derived Fragments as Biomarkers for Pancreatic Neuroendocrine Tumors (PanNET) Published in 2020 Listed under Other Download V. Andreasi, S. Partelli, M. Manzoni, B. Colombo, F. Muffatti, A. Corti, M. Falconi ABSTRACT ID: 168 O9 - Patient Experience with Somatostatin Analog Treatments for Neuroendocrine Tumors: Insight from Qualitative Interviews Published in 2020 Listed under Other Download C. Seo, E. Horodniceanu, R. Shah, G. Goldstein, D. Ray, B. Bennett, A. Phan, K. McCarrier ABSTRACT ID: 171 5 10 15 20 25 30 50 100
